Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy by Hombach, Vinzenz et al.
.....................................................................................................................................................................................
.....................................................................................................................................................................................
CLINICAL RESEARCH
Heart failure/cardiomyopathy
Electrocardiographic and cardiac magnetic
resonance imaging parameters as predictors
of a worse outcome in patients with
idiopathic dilated cardiomyopathy
Vinzenz Hombach1*, Nico Merkle1, Jan Torzewski1, Johann M. Kraus2,
Markus Kunze1, Oliver Zimmermann1, Hans A. Kestler2†, and Jochen Wo ¨hrle1†
1Clinic of Internal Medicine II, University Hospital Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany; and
2Neural Information Processing System, University of
Ulm, Ulm, Germany
Received 8 August 2008; revised 4 May 2009; accepted 2 July 2009; online publish-ahead-of-print 24 July 2009
Aims Clinical parameters are weak predictors of outcome in patients with idiopathic dilated cardiomyopathy (IDC). We
assessed the prognostic value of cardiac magnetic resonance (CMR) parameters in addition to conventional clinical
and electrocardiographic characteristics.
Methods
and results
One hundred and forty-one IDC patients were studied. QRS and QTc intervals were measured in 12-lead surface
electrocardiogram. Patients were followed for median 1339 days, including 483 patient-years. The primary
endpoint—cardiac death or sudden death—occurred in 25 (18%) patients, including 16 patients with cardiac
death, 3 patients with sudden cardiac death (SCD), and 6 patients with ICD shock. Late gadolinium enhancement
(LGE) was detected in 36 patients (26%). Kaplan–Meier survival analysis displayed QRS .110 ms (P ¼ 0.010), the
presence of LGE (P ¼ 0.037), and diabetes mellitus (P , 0.001) as signiﬁcant parameters for a worse outcome.
Multivariable analysis revealed cardiac index (P , 0.001), right ventricular end-diastolic volume index (RVEDVI)
(P ¼ 0.006) derived from CMR imaging, the presence of diabetes mellitus (P ¼ 0.006), and QRS .110 ms
(P ¼ 0.045) as signiﬁcant predictors for the primary endpoint.
Conclusion Cardiac index and RVEDVI derived from CMR imaging in addition to QRS duration .110 ms from conventional
surface ECG and diabetes mellitus provide prognostic impact for cardiac death and SCD in patients with IDC.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
The natural history of patients with idiopathic dilated cardiomyo-
pathy (IDC) is variable. Some patients have minimal or no symp-
toms and the progression of the disease is unclear. On the other
hand, symptomatic patients seem to experience progressive
deterioration, and 10–50% with heart failure may succumb
within 1 year.
1 The annual mortality rate for a typical patient
with heart failure was estimated to be 10–13%.
2 Clinical predictors
such as advanced age, protodiastolic gallop, failure of the myo-
pathic ventricle to respond to inotropic stimulation, and ventricu-
lar arrhythmias have been identiﬁed as risk factors of dying from
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3 A prolonged QRS duration and a reduced left ventricular
ejection fraction (LVEF) have been associated with a worse prog-
nosis in patients with IDC.
4–7
Cardiac magnetic resonance (CMR) imaging is a powerful tool to
assess morphology and myocardial function as well as changes in
tissue structure. Myocardial damage, viability, and scarring have
been frequently studied in patients with coronary artery disease
(CAD) post-myocardial infarction using pathological late uptake
of extracellular MR contrast media by the ventricular myocardium
(late gadolinium enhancement, LGE).
8–11 In IDC patients, the evi-
dence of LGE is associated with a worse prognosis compared with
those without LGE.
12,13 Studies on LGE behaviour in patients with
IDC and their prognostic signiﬁcance when compared with other
CMR parameters are scarce.
12,13 Furthermore, classical prognostic
parameters such as QRS duration,
4–7,14 right ventricular (RV)
dilation,
15–17 or LVEF
4,5,14,18,19 have not been taken into account
for prognostic impact in combination with LGE in IDC patients.
However, the predictive value of any single parameter is not
strong enough to assess the clinical course and outcome in an indi-
vidual patient with reasonable accuracy. Therefore, the aim of this
study was to assess the prognostic value of CMR parameters in
addition to clinical and electrocardiographic characteristics.
Methods
Patients
One hundred and ﬁfty-three consecutive patients with IDC according
to the deﬁnition of the Word Health Organization
20 were enrolled
during a period of 4 years. Diagnosis was established by clinical exam-
ination, echocardiography, and normal coronary angiograms. No
patient had history of previous coronary intervention or myocardial
infarction. A normal coronary angiogram was deﬁned as coronary
arteries without any stenoses or occlusions. The border of the coron-
ary arteries had to be without irregularities exceeding a luminal diam-
eter reduction of .30%.
Cardiac magnetic resonance study was performed for evaluation of
RV and LV function and LGE. All patients had chronic heart failure of at
least 12-month duration and had presented with typical onset and
clinical signs of heart failure. Cardiac magnetic resonance studies
were performed with the patients being in a haemodynamic stable situ-
ation free from catecholamines. None of the patients showed a typical
subendocardial or transmural LGE in the supplied territory of a coron-
ary artery as a possible result of myocardial damage by coronary
emboli.
Four patients did not undergo CMR imaging study because of claus-
trophobia resulting in a population of 149 patients. Sixty-three of 149
patients (42%) underwent myocardial biopsy for molecular analysis of
virus persistence or molecular markers of chronic inﬂammation as
described elsewhere.
21 Eight patients with inﬂammatory cardiomyopa-
thy due to chronic inﬂammation in myocardial biopsy (.10
CD2-positive cells/mm
2)
21–23 were excluded resulting in a study
population of 141 patients.
Patients with atrial ﬁbrillation (n ¼ 56) were not excluded in order
to enrol a real-world patient population with IDC. The study was
approved by the local Ethics Committee and all patients gave their
written informed consent. The investigation conforms to the principles
outlined in the Declaration of Helsinki.
QRS and QTc interval measurement
At the day of CMR study, a 12-lead ECG was recorded at a paper
speed of 50 mm/s on a digital ECG recorder (GE Medical Systems,
Information Technologies, Freiburg, Germany). The intervals were
automatically analysed (CardioSoft Version 4.2). Heart rate
correction was done by the Bazett formula, prolonged QRS was
deﬁned as a QRS width of .110 ms, and prolonged QTc as a QTc
interval of .440 ms.
Cardiac magnetic resonance protocol
and data analysis
Cardiac magnetic resonance imaging was performed on a 1.5 T whole-
body scanner (Intera CV, Philips Medical Systems, Best, The
Netherlands). To deﬁne the position and axis of the left ventricle,
three survey scans were performed along right–left, anterior–posterior,
and foot–head orientation. Resting LV and RV function was deter-
mined with 3D cine imaging applying a multiple breath hold segmented
k-space balanced FFE sequence (steady-state free precession) in short-
and long-axis views aligned with the true heart axis. Parallel imaging
was employed for all scans to minimize acquisition time. Depending
on the ﬁeld of view, in-plane resolution was between 1.5   1.8 and
2.3   1.8 mm with a slice thickness of 10 mm for the functional
scans. The short-axis scans covered the whole LV and RV with 10–
14 contiguous slices with a temporal resolution of 34 cardiac phases.
Around 10–15 min after infusion of 0.2 mmol/kg body weight
gadolinium-diethylenetriaminepentaacetate (Magnevist, Schering,
Germany), a late enhancement study using a 3D spoiled turbo Gradi-
ent Echo sequence with a selective 1808 inversion recovery pre-pulse
was acquired in the short axis covering the whole LV (20–22 5 mm
slices). Two to three long-axis views with a similar 2D sequence
were additionally performed. The pre-pulse delay (range, 200–
250 ms) was adjusted individually using a Look–Locker sequence.
24
Cardiac magnetic resonance protocols were identical during the
whole series of patient investigations.
Left ventricular and RV volumes and functional parameters were
analysed off-line on a ViewForumTM Workstation (Philips) using short-
axis volumetry. Papillary muscles were assigned to the myocardium.
Short- and long-axis images were scrutinized by two observers for
the presence of LGE. Late gadolinium enhancement was quantitatively
assessed on a ViewForum Workstation.
Follow-up and endpoints
Patients were followed by a clinical visit or telephone call using a ques-
tionnaire for evaluation of NYHA functional status, actual medication,
new cardiac events, worsening of disease state, and occurrence of pre-
speciﬁed endpoints. The composite primary endpoint was deﬁned as
cardiac death or sudden cardiac death (SCD) from malignant ventricu-
lar arrhythmias (ventricular ﬂutter or ﬁbrillation). The secondary end-
point was deﬁned as cardiac death or SCD or rehospitalization for
decompensated heart failure.
Statistical analysis
Continuous variables are presented as mean+1 SD. Discrete vari-
ables are expressed as counts and percentages compared by means
of x
2 analysis. Tests were always two-sided. Survival curves were esti-
mated by the Kaplan–Meier method and compared by the log-rank
test. Multivariable Cox proportional hazards models were used to
calculate hazard ratios (HRs) and 95% conﬁdence intervals (CIs).
We constructed two separate multivariable models to critically
assess the prognostic value of the parameters, one for the primary
endpoint and one for the secondary endpoint. Here, we have
V. Hombach et al. 2012applied Cox proportional hazards regression and used a bootstrap
approach(n ¼ 1000),overthecases(asinSauerbreiandSchumacher
25),
that has a nested selection procedure over all parameter subsets
(evaluation of all parameter subsets and Akaike information criterion)
to determine the most relevant parameters in each resampling step,
i.e. only the most frequent variables ( 70%) from all runs are used
in accordance with adjustment of the number of variables to the
number of events during follow-up
26,27 and collinearity is accounted
for. The linearity assumption for continuous variables of the Cox
model was assessed by comparing two models for each covariate,
one model with the covariate as a linear term and a second model
additionally including the covariate as a quadratic term. The linearity
assumption could not be veriﬁed for age. The proportional hazards
assumption was veriﬁed for all parameters except NYHA status
with the method by Grambsch and Therneau.
28 For inclusion into
the multivariable model, only parameters were considered that were
signiﬁcant in the univariate analysis. Statistical signiﬁcance was
accepted for P , 0.05. All statistical analyses were conducted with Sta-
tistica version 6.1 (Statsoft Inc., Tulsa, OK, USA) and R version 2.81
(www.r-project.org).
Results
One hundred and forty-one consecutive patients with IDC were
enrolled and prospectively followed. Patients were included
between February 2002 and February 2006. Patient characteristics
are summarized in Table 1 and are differentiated into those with
and without LGE.
Clinical status and risk factors
Sixty-ﬁve patients (46%) were in NYHA functional class III and 43
(31%) in class IV. Patients were set on maintenance quadruple drug
therapy with beta-blockers, ACE-inhibitors/AT2-receptor block-
ers, aldosterone antagonists, and diuretics (Table 1). Twenty-one
patients received a biventricular pacing device and 34 patients an
intracardiac deﬁbrillator (ICD) including 4 with biventricular
pacing mode.
Cardiac magnetic resonance parameters
Mean values of heart rate, LV and RV end-diastolic and end-systolic
volumes and indices, ejection fraction (EF), and cardiac index (CI)
are listed in Table 2. Patients in NYHA class III or IV had a signiﬁ-
cantly lower LVEF (30+14 vs. 39+12%; P , 0.002) and a signiﬁ-
cantly lower CI (2.6+0.8 vs. 3.1+0.6 L/min/m
2; P , 0.014) when
compared with those in NYHA class I or II. Late gadolinium
enhancement was present in 36 patients (26%). Distribution
pattern of LGE was mid-wall, subepicardial, or diffuse. Patients
with LGE showed subepicardial pattern in 14 of 36 (38.9%). Late
gadolinium enhancement in relation to LV muscle mass was
5.6+4.7% (range, 1.2–25.6%).
Follow-up
Follow-up data were obtained in all 141 patients. Patients were fol-
lowed for a median of 1339 days (inter-quartile range, 822–1676
days). Data were collected for a total of 483 patient-years of
follow-up. During follow-up, 4 patients died from non-cardiac
...............................................................................................................................................................................
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Table 1 Patient characteristics
All patients With LGE No LGE
141 36 105
Male, n (%) 108 (76.6) 30 (83.3) 78 (25.7)
Female, n (%) 33 (23.4) 6 (16.7) 27 (25.7)
Age (years) 56.1+13.3 59.7+11.2 54.8+13.8
Cardiovascular risk factors, n (%)
Diabetes mellitus 23 (16.3) 9 (25.0) 14 (13.3)
Arterial hypertension 55 (39.0) 13 (36.1) 42 (40.0)
Hypercholesterolemia 53 (37.6) 14 (38.9) 39 (37.1)
Smoking 41 (27.5) 12 (30) 29 (26.6)
Familial disposition 21 (14.9) 8 (22.2) 13 (12.4)
BMI (kg/m
2) 26.7+4.9 26.4+4.3 26.8+5.1
NYHA class I, n (%) 17 (12.1) 5 (13.9) 12 (11.4)
NYHA class II, n (%) 16 (11.3) 4 (11.1) 12 (11.4)
NYHA class III, n (%) 65 (46.1) 17 (47.2) 48 (45.7)
NYHA class IV, n (%) 43 (30.5) 10 (27.8) 33 (31.4)
QRS .110 ms 94 (66.7) 29 (80.6) 65 (61.9)
QTc .440 ms 65 (46.1) 18 (50.0) 47 (44.8)
ACE-inhibitor, n (%) 123 (87.2) 33 (91.7) 90 (85.7)
Beta-blocker, n (%) 127 (90.1) 33 (91.7) 94 (89.5)
Spironolactone, n (%) 105 (74.5) 28 (77.8) 77 (73.3)
Diuretic, n (%) 127 (90.1) 32 (88.9) 95 (90.5)
Phenprocoumone, n (%) 69 (48.9) 23 (63.9) 46 (43.8)
BMI, body mass index; NYHA, New York Heart Association; ACE, angiotensin-converting enzyme.
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SCD. Additional six surviving patients with an ICD experienced
shocks for ventricular ﬂutter/ﬁbrillation and were included in the
endpoints as a surrogate parameter of SCD. Thus, the total
number of cardiac deaths and SCD was 25 in 141 patients
(18%). The secondary endpoint occurred in 53 patients (37.6%).
Events occurred more often in patients with LGE when compared
with those without LGE. Hazard ratio was 2.26 with a 95% CI of
1.03–4.99 (P ¼ 0.043, Table 3 and Figure 1).
Univariate and multivariable analyses
and Kaplan–Meier curves
Among the clinical, electrocardiographic, haemodynamic, and CMR
data, univariate analyses revealed diabetes mellitus, QRS duration
.110 ms, right ventricular end-diastolic volume index (RVEDVI),
CI, LVEF, RVEF, and the presence of LGE as signiﬁcant predictors
for the primary endpoint. Signiﬁcant predictors for occurrence of
the primary endpoint in multivariable analysis were diabetes melli-
tus (P ¼ 0.006), QRS .110 ms (P ¼ 0.045), RVEDVI (P ¼ 0.006),
and CI (P , 0.001, Table 3).
Signiﬁcant predictors for the secondary endpoint from univari-
ate analysis were QRS .110 ms, QTc .440 ms, left ventricular
end-diastolic volume index (LVEDVI), RVEDVI, LVEF, and RVEF.
In multivariable analysis, QRS .110 ms (P ¼ 0.026), QTc
.440 ms (P ¼ 0.047), and RVEDVI (P ¼ 0.010) were signiﬁcant
predictors for the secondary endpoint (Table 4).
Kaplan–Meier analysis for the primary endpoint (Figure 1)
showed that QRS .110 ms, the presence of LGE, and the pres-
ence of diabetes mellitus were associated with a signiﬁcant
worse outcome in IDC patients when compared with those
without the corresponding criteria. Interestingly, patients with
LGE in CMR imaging had signiﬁcantly more often a QRS interval
.110 ms when compared with patients without LGE (80.6 vs.
61.9%, P ¼ 0.034).
Discussion
In a large cohort of 141 patients with IDC, we were able to
demonstrate that in addition to CI and RVEDVI derived from
CMR imaging, QRS duration .110 ms and diabetes mellitus had
independent prognostic impact on the composite endpoint SCD
and cardiac death.
Relevance of diagnostic workup of
idiopathic dilated cardiomyopathy
With regard to prognostic aspects, the conﬁrmation of IDC diag-
nosis is highly relevant, because mechanisms and incidence of
cardiac death and SCD may be different in chronic inﬂammatory
compared with non-inﬂammatory cardiomyopathy. Diagnosis of
IDC was established by clinical examination, echocardiography,
and evidence of normal coronary angiograms. In addition, with
myocardial biopsy in a large number of our patients, we were
able to identify individuals with inﬂammatory cardiomyopathy.
Those patients were excluded in order to study a homogenous
population with IDC.
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Table 3 Univariate and multivariable analyses for predictors of primary endpoint
Univariate analysis Multivariable analysis Resampling procedure
HR (95% CI) P-value HR (95% CI) P-value Frequency
Diabetes 4.38 (1.98–9.66) ,0.001 3.19 (1.40–7.29) 0.006 0.90
QRS .110 ms 5.43 (1.28–23.1) 0.022 4.64 (1.04–20.78) 0.045 0.71
QTc .440 ms 1.57 (0.71–3.5) 0.261
LVEDVI 1.00 (1.00–1.01) 0.238
RVEDVI 1.01 (1.00–1.02) 0.003 1.01 (1.00–1.02) 0.006 0.76
CI 0.45 (0.25–0.83) 0.010 0.35 (0.19–0.65) ,0.001 0.95
LVEF 0.95 (0.92–0.99) 0.013 0.45
RVEF 0.97 (0.95–0.99) 0.022 0.38
LGE 2.26 (1.03–4.99) 0.043 0.54
................................................................................
Table 2 Cardiac magnetic resonance imaging
characteristics
All patients With LGE No LGE
141 36 105
LVEDV (mL) 271+104 282+88 268+108
LVESV (mL) 194+103 209+89 189+108
LVEF (%) 32+14 28+12 34+15
CI (L/min/m
2) 2.76+0.79 2.53+0.71 2.84+0.80
LVEDVI (mL/m
2) 141+56 150+49 139+58
LVESVI (mL/m
2) 101+56 111+48 98+59
RVEDV (mL) 166+58 182+65 161+55
RVESV (mL) 90+55 108+62 84+51
RVEF (%) 50+16 43+16 52+15
RVEDVI (mL/m
2)8 7 +33 94+32 85+33
RVESVI (mL/m
2)4 7 +29 58+33 43+27
Heart rate (b.p.m.) 71+14 69+15 72+14
EDV, end-diastolic volume; ESV, end-systolic volume; EDVI, end-diastolic volume
index; ESVI, end-systolic volume index.
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In univariate and multivariable analyses, a QRS interval of .110 ms
was predictive for the primary as well as the secondary endpoint.
A QTc interval of .440 ms had also prognostic impact for the sec-
ondary endpoint. A prolonged QRS complex of .110–120 ms
has been shown to be predictive for a worse outcome in patients
with congestive heart failure.
4–7 These cohorts included patients
with mixed aetiologies of cardiomyopathy with ischaemic, non-
ischaemic, or valvular genesis, whereas we focused on patients
with IDC. Prolonged QTc interval (.440 ms) was a strong, inde-
pendent predictor for mortality in patients with heart failure and
elevated B-type natriuretic peptide.
29 Few reports exist on pure
IDC patients, such as the study of Morgera et al.
30 on 78 consecu-
tive IDC patients using signal-averaged ECG, 24 h ECG monitoring,
and electrophysiological study to assess prognostic parameters.
They found an HV interval of .55 ms, a combination of frequent
and repetitive ventricular ectopic beats, and poor LV function as
independent predictors of death or cardiac transplantation. The
association of a prolonged HV interval with a wide QRS
complex (.110 ms) yielded a strong risk for future arrhythmic
events. Amiya et al.
14 were able to show that a QRS duration of
.120 ms was a signiﬁcant predictor for cardiac death or hospital-
ization in 78 patients with non-ischaemic dilated cardiomyopathy
within a follow-up period of 35.6+27.8 months. Of note, non-
ischaemic dilated cardiomyopathy was carefully diagnosed by echo-
cardiography, coronary angiography, and myocardial biopsy.
Furthermore, CI was measured with Swan–Ganz thermodilution
at rest. Mean EF was 26.3% by echocardiography. Cardiac index
was still normal with 2.66+0.84 L/min/m
2. Comparable results
have been obtained with another measurement technique using
inert gas rebreathing.
31 We derived both parameters (LVEF and
CI) from CMR imaging and revealed similar results. The mean
LVEF was 32% and CI was 2.76+0.79 L/min/m
2, both measured
at rest.
Left ventricular ejection fraction has been demonstrated to be a
strong predictor for cardiac mortality in patients with heart
failure.
4,5,14,18,19 Amiya et al.
14 also analysed CI and LVEF for prog-
nostic impact of cardiac death or hospitalization because of
deterioration of heart failure, comparable to our secondary end-
point. In our population, LVEF was a univariate predictor for the
primary as well as the secondary endpoint, but failed to be predic-
tive in multivariable analysis. Other trials did not include LVEF, CI,
and RV parameters for analysis of prognostic impact. With CMR
imaging, those parameters can be easily and accurately measured
non-invasively.
32 Cardiac index was a relevant prognostic par-
ameter for cardiac death and SCD (HR, 0.35). In our population,
the haemodynamic parameter CI outperformed LVEF in determin-
ing risk for cardiac death. Very recently, two CMR studies
12,13
reporting a prognostic impact of LGE in patients with non-
ischaemic cardiomyopathy did not demonstrate any prognostic rel-
evance of LVEF, whereas CI and electrocardiographic parameters
were not analysed.
Interestingly, we were able to demonstrate that diabetes mellitus
by univariate and multivariable analyses was a signiﬁcant predictor
Figure 1 Kaplan–Meier curves for the primary endpoint according to QRS duration, late gadolinium enhancement, and diabetes mellitus
(panels from left to right). Survival curves were signiﬁcantly different for QRS duration  110 vs. .110 ms (P ¼ 0.010), the presence or
absence of late gadolinium enhancement (P ¼ 0.037), and the presence or absence of diabetes mellitus (P , 0.001).
Electrocardiographic and CMR imaging parameters 2015for the primary endpoint. Our results are in line with previous
reports,
33,34 showing in patients with non-ischaemic cardiomyopa-
thy a three to seven times higher risk for mortality in patients with
diabetes mellitus compared with those without. Furthermore,
insulin resistance has been recently discussed as a primary aetiolo-
gical factor in the development of non-ischaemic heart failure,
35,36
which clinically often manifests as type II diabetes. The prognostic
impact of insulin resistance has been shown to be independent of
LVEF.
35
Furthermore, we measured RV parameters which have rarely
been analysed for their prognostic impact in IDC patients so far.
A preserved RVEF assessed by ﬁrst-pass radionuclide ventriculo-
graphy in patients with advanced heart failure referred for evalu-
ation for cardiac transplantation was a powerful predictor for
survival.
15 With echocardiography, RV systolic and diastolic dys-
function was associated with a poor prognosis in 177 patients
with ischaemic or IDC.
16 In our IDC population, RVEDVI was a
predictor of both, the primary and secondary endpoints in univari-
ate as well as in multivariable analysis. Right ventricular ejection
fraction was associated with an increased risk for both endpoints
in univariate analysis. Due to ventricular interaction, an increase
in RV diastolic volume and a decline in RV systolic function have
been shown to impair LV systolic and diastolic function.
37–39 In
an IDC population including 100 patients, RV dilation determined
by echocardiography was analysed for prognostic impact.
17
Patients with RV dilation had a three-fold higher mortality over
4 years and more rapidly deterioration of LV function compared
with patients with less initial RV dilation.
Late gadolinium enhancement was univariately associated with a
signiﬁcant worse outcome as recently reported.
12,13 Kaplan–Meier
curves signiﬁcantly differed for patients with LGE when compared
with those without. In multivariable analysis, LGE was not associ-
ated with an independent prognostic impact. Assomull et al.
12
were able to show that mid-wall ﬁbrosis in patients with dilated
cardiomyopathy was predictive for all-cause mortality and cardio-
vascular hospitalization. Late gadolinium enhancement also
remained relevant with inclusion of RVEF, LGE, LVEF, LVEDV,
and LVESV in the multivariable model. However, RV volumes,
CI, and classical electrocardiographic parameters were not
integrated.
There are several important differences between our population
and the group studied by Wu et al.
13 The patient cohort in the
study of Wu et al.
13 consisted exclusively of IDC patients with
an LVEF ,35% selected for ICD implantation. This very hom-
ogenous but small and selected group of the sickest IDC patients
does not represent the total spectrum of IDC patients, as we have
studied. With myocardial biopsy in 42% of the patients, we were
able to exclude patients with chronic inﬂammation. Several charac-
teristics and results are consistent between both studies: CAD was
excluded by angiography. In the Wu study,
13 42% (n ¼ 27/65)
patients showed LGE comparable to 34% (n ¼ 36/105) in our
population. Patients with and without LGE had similar baseline
characteristics. Kaplan–Meier curves showed a signiﬁcant differ-
ence between patients with LGE and those without. At this
point, we like to stress that in our experience and other
studies,
12,13 the intramural to subepicardial pattern and potentially
diffuse distribution of LGE in patients with IDC is quite different
from the preferred subepicardial distribution of LGE in the infero-
lateral wall in patients with acute myocarditis.
40
In multivariable analysis, LGE remained not signiﬁcant in our
trial. With the intention to identify IDC patients at risk, we did
not restrict our analysis to CMR parameters alone. We also inte-
grated well-known predictors for cardiac events from 12-lead
surface electrocardiography.
4–7 Interestingly, the presence of
LGE was associated with a signiﬁcant higher frequency of a pro-
longed QRS interval. The QRS width in ECG is a summary of
various factors. Among others, this interval is inﬂuenced by
LVEF, LVEDVI, and LGE and has a strong prognostic impact in
patients with IDC even in combination with CMR parameters.
No previous study combined classical electrocardiographic par-
ameters with modern CMR data to assess prognosis in IDC
patients. In our IDC population, a prolonged QRS interval outper-
formed LGE seen in CMR. Furthermore, we also included RV par-
ameters into the analysis, since a depressed RV function had been
previously associated with a higher event rate. In contrast, Wu
et al.
13 did not analyse RV parameters. Finally, we did not focus
on LGE alone, since patients without LGE are not free from malig-
nant ventricular arrhythmias. The combination of electrocardio-
graphic and CMR parameters allows a risk stratiﬁcation for
patients with as well as without LGE.
........................................... ........................................... ..............................
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Table 4 Univariate and multivariable analyses for predictors of secondary endpoint
Univariate analysis Multivariable analysis Resampling procedure
HR (95% CI) P-value HR (95% CI) P-value Frequency
Diabetes 1.50 (0.79–2.85) 0.211
QRS .110 ms 2.32 (1.13–4.77) 0.022 2.39 (1.11–5.12) 0.026 0.86
QTc .440 ms 1.74 (1.01–2.99) 0.046 1.76 (1.01–3.07) 0.047 0.70
LVEDVI 1.00 (1.00–1.01) 0.009 0.28
RVEDVI 1.01 (1.00–1.02) 0.008 1.01 (1.0–1.02) 0.010 0.76
CI 0.72 (0.48–1.06) 0.096
LVEF 0.97 (0.94–0.99) 0.005 0.61
RVEF 0.98 (0.96–1.00) 0.040 0.32
LGE 1.45 (0.82–2.58) 0.202
V. Hombach et al. 2016Study limitations
No exercise test during CMR imaging was performed to measure
the reduced increase in CI in IDC patients with reduced LVEF.
Another CMR study was not performed during follow-up,
because we were primarily interested in the prognostic signiﬁcance
of CMR parameters assessed at entry of the patients into the study.
We performed MRI scans with particular attention to image quality
to minimize inﬂuences of hampered image quality and artefacts in
the detection of even small amounts of LGE. However, the extent
of LGE in patients with IDC is typically small and quantitative
assessment of diffuse LGE pattern is quite challenging limiting the
accuracy of the quantitative assessment. Although myocarditis
was not suspected from the clinical proﬁle, myocardial biopsy
showed the presence of virus persistence in six patients. We did
not exclude these six patients from analysis since biopsy is
usually not performed in those patients and the clinical course
was not different with one primary and two secondary events.
On the other hand, myocardial biopsy was not performed in all
patients and biopsy is also limited by the possibility of false-negative
results. Although we deﬁned inﬂammatory cardiomyopathy as the
presence of .10 inﬁltrating lymphocytes/mm
2, other groups are
using a cut-off of .7
41 or .14 cells/mm
2.
42 Another possible
limitation of this study may be the number of events per variable
in the initial multivariate model.
Conclusions
We were able to demonstrate that in addition to CI and RVEDVI
derived from CMR imaging, a QRS duration of .110 ms and the
presence of diabetes mellitus provide prognostic impact in patients
with IDC. The practical advantage is that the electrocardiographic
and CMR features can be derived from two non-invasive tech-
niques with highest precision and without complicated analysis
techniques.
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